Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Endocrine 2Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 285Head and Neck Neoplasms 250Carcinoma, Non-Small-Cell Lung 95Thyroid Neoplasms 92Melanoma 68Mouth Neoplasms 67Nasopharyngeal Carcinoma 64Oropharyngeal Neoplasms 63Breast Neoplasms 54Colorectal Neoplasms 49Lung Neoplasms 47Ovarian Neoplasms 45Neoplasm Metastasis 45Neoplasms 41Uterine Cervical Neoplasms 39Carcinoma, Squamous Cell 39Carcinoma, Renal Cell 34Triple Negative Breast Neoplasms 31Stomach Neoplasms 31Laryngeal Neoplasms 31Endometrial Neoplasms 29Carcinoma 29Sarcoma 28Esophageal Neoplasms 28Pancreatic Neoplasms 27Salivary Gland Neoplasms 26Prostatic Neoplasms 25Thyroid Cancer, Papillary 23Urinary Bladder Neoplasms 22Hypopharyngeal Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parkinson Disease × Head & Neck × 90 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡